MS: Busting the Myths
February 12, 2021 | Advocacy, Life with MS, Treatments
Media Release – 12 February 2021 – Released by PHARMAC PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their […]
February 12, 2021 | Advocacy, Life with MS, Treatments
(Pharmac Media Release – 12 February 2021) PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, […]
January 26, 2021 | Covid-19, Life with MS, Research, Treatments
This article, written by the Journal of Multiple Sclerosis and related disorders, (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum. The objective was to better understand the SARS-CoV-2 infection in […]
December 4, 2020 | Advocacy, Life with MS, Treatments
On Friday 27th November 2020, Pharmac released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a standard Special Authority. Consultation closes 4pm […]
November 27, 2020 | Advocacy, Life with MS, Treatments
Media Release No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS? A six year battle to allow multiple sclerosis patients continued access to vital funded drug treatments may soon be over, with news that Pharmac is finally […]